Showing results (871-880 of 2,411) with videos related to
Sort By:
Pageof 242
Journal of Medical Economics|September 23, 2009
Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorderTatia Chay Woodward, Eskinder Tafesse, Peter Quon, et al.Journal of Medical Economics|September 12, 2009
Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspectiveLouis Bessette, Nancy Risebrough, Nicole Mittmann, et al.Journal of Medical Economics|August 27, 2009
Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic painN Wu, S Chen, L Boulanger, et al.Journal of Medical Economics|May 5, 2010
Burden of illness for patients with non-dialysis chronic kidney disease and anemia in the United States: review of the literatureFloortje E van Nooten, Julia Green, Ruth Brown, et al.Journal of Medical Economics|September 28, 2011
Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD managementMelissa Roberts, Douglas Mapel, Hans Petersen, et al.Journal of Medical Economics|June 15, 2011
Healthcare costs of fast-acting insulin analogues versus short-acting human insulin for Danish patients with type 2 diabetes on a basal-bolus regimenTorsten E Christensen, Jens Gundgaard, Trine PilgaardJournal of Medical Economics|February 16, 2012
The threshold rate of oral atypical anti-psychotic adherence at which paliperidone palmitate is cost savingNatalie C Edwards, Erik Muser, Dilesh Doshi, et al.Journal of Medical Economics|November 25, 2011
Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trialJun R Chiong, Sonnie Kim, Jay Lin, et al.Journal of Medical Economics|October 22, 2011
Early discontinuation and suboptimal dosing of duloxetine treatment in patients with major depressive disorder: analysis from a US third-party payer perspectiveZhanglin Cui, Douglas E Faries, Steven Gelwicks, et al.Journal of Medical Economics|December 17, 2011
Economic evaluation of a 100% whey-based partially hydrolyzed infant formula in the prevention of atopic dermatitis among Danish childrenMichael Iskedjian, Ferdinand Haschke, Bechara Farah, et al.Pageof 242